| Clinical Study "Common" Name (formal title) | Number of enrollees | Funding source (pharma/NIH) | Year complete | Primary publication | Full study treatment protocol |
|---|---|---|---|---|---|
| PHOTON [Aflibercept 8 mg in diabetic macular edema: 156-week results from the PHOTON extension] | n = 265 |
Regeneron Pharmaceuticals, Inc. NCT04429503 |
2024 | Brown D. Aflibercept 8 mg in diabetic macular edema: 156-week results from the PHOTON extension. Presented at: the Macula Society 48th Annual Meeting; 2025; February 12-15, 2025; Charlotte Harbor, FL. |
|